CORC

在结果中检索

CORC

浏览/检索结果: 共45条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) 会议论文
作者:  Zhou, J.;  Eng-Wong, J.;  Mao, Y.;  Althaus, B.;  Liao, N.
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2 会议论文
作者:  Knox, J.;  Cheng, A.;  Cleary, S.;  Galle, P.;  Kokudo, N.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
A Phase IIIb Trial of Afatinib in EGFRm plus NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Phase II trial of tepotinib vs sorafenib for treatment-naive advanced hepatocellular carcinoma (HCC) in Asian patients 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Exposure to PM2.5 Activates Hypothalamic-Pituitary-Adrenal Axis in Mouse Models and Humans 会议论文
作者:  Xu, Y.;  Chen, M.;  Zhou, J.;  Li, H.;  Zhang, X.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Pamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China 会议论文
作者:  Wu, X.;  Wang, J.;  Zhou, Q.;  Gu, T.;  Zhang, K.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Can liver transplantation or hepatic resection achieve cure for hepatocellular carcinoma? 会议论文
作者:  Cucchetti, A.;  Sposito, C.;  Yang, T.;  Mazzaferro, V.;  Carlis, L. D.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC) 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC) 会议论文
作者:  Wu, Y.;  Chang, J.;  Zhang, L.;  Tu, H.;  Wu, L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer 会议论文
作者:  Liu, H.;  Li, G.;  Yu, J.;  Su, X.;  Sun, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace